RxDoctor Payments Data

Anna Melissa Pacis, MD

Family Medicine · New Lenox, ILNPI 1891016580

Payments from drug & device makers

$219in general payments, 2019–2025

Across 11 payments — averaging $19.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$62
  • Abbott$49
  • AbbVie$38
  • Medtronic$25
  • Daiichi Sankyo Inc.$17
  • AstraZeneca$16
  • plus $14 from 1 others

What the payments were for

  • Food & beverage$219100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novo Nordisk3$62
Abbott2$49
AbbVie2$38
Medtronic1$25
Daiichi Sankyo Inc.1$17
AstraZeneca1$16
Pfizer1$14

How this compares

$219 in reported general payments places this provider in the 50th percentile of 4,116 family medicine providers in Illinois.

See all family medicine providers in Illinois

Medicare billing

Part B allowed, 2024
$96,093
Medicare patients
309
Services billed
1,205

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide68$108,105
JanuviaSitagliptin Phosphate27$37,076
EliquisApixaban27$37,057
JardianceEmpagliflozin30$31,862
TrulicityDulaglutide16$31,663
TradjentaLinagliptin20$27,941
MounjaroTirzepatide17$24,568
Trelegy ElliptaFluticasone/Umeclidin/Vilanter28$22,751
Spiriva RespimatTiotropium Bromide13$7,539
MyrbetriqMirabegron12$7,319
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate19$5,083
Humalog Kwikpen U-100Insulin Lispro12$5,081
Lantus SolostarInsulin Glargine,hum.Rec.Anlog35$3,824
Levothyroxine Sodium292$3,815
Fluticasone-SalmeterolFluticasone Propion/Salmeterol24$3,762

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$62$108,10568 claims
PfizerEliquis$14$37,05727 claims
AbbVieSynthroid$38$1,67338 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 4,116 family medicine providers in Illinois.

Other family medicine in New Lenox

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →